The Egyptian Orthopaedic Journal,
Год журнала:
2023,
Номер
58(2), С. 67 - 82
Опубликована: Апрель 1, 2023
Abstract
Background
The
pandemic
of
COVID-19
virus
had
led
to
another
avascular
necrosis.
Aim
To
evaluate
the
altered
clinical
and
radiological
presentation
COVID-19-related
AVN
hip.
Methods
This
study
included
42
patients
with
head
femur
who
were
presented
outpatient
clinic
Kafr
El
Sheikh
University
Hospital.
Patients
classified
into
three
main
groups.
first
group
COVID
infection
received
steroid
therapy
for
their
pulmonary
manifestations.
second
without
receiving
therapy.
final
hip
after
vaccination
taking
any
Results
related
infection.
more
susceptible
development
at
(a)
lower
threshold
dose
(900
g)
(b)
earlier
onset
(less
than
a
month).
Conclusions
conclude,
there
is
silent
epidemic
cases
presenting
daily
in
our
clinics
AVN.
Background:
The
COVID-19
pandemic
has
presented
numerous
challenges
to
global
healthcare
system
and
emerging
evidence
suggests
a
potential
link
between
treatment,
specifically
steroid
therapy,
the
development
of
avascular
necrosis
(AVN)
hip.
This
review
aims
provide
comprehensive
overview
recent
studies
case
reports
investigating
relationship
COVID-19,
corticosteroid
AVN.
Understanding
nuances
AVN
in
context
is
crucial
for
professionals
navigate
treatment
decisions
mitigate
complications.
Materials
Methods:
Preferred
Reporting
Items
Systematic
Reviews
Meta-Analysis
(PRISMA)
was
used
systematic
until
September
1st,
2023.
full-texts
remaining
twenty-three
(n=23)
articles
were
independently
reviewed
by
authors
this
review.
Conclusions:
association
therapy
hip
noteworthy
concern
even
though,
no
evident
duration
cumulative
dosage
medication,
maximum
daily
received,
presence
Further
research
with
larger
cohorts
long-term
follow-up
needed
better
understand
causative
optimal
management
strategies
Revista de Medicina,
Год журнала:
2024,
Номер
103(4)
Опубликована: Авг. 29, 2024
Non-traumatic
osteonecrosis
of
the
femoral
head
(ONHF)
is
characterized
by
cell
death
osteocytes
and
alterations
in
osteoblasts
osteoclasts,
often
caused
prolonged
use
corticosteroids.
Other
risk
factors
include
autoimmune
diseases,
alcohol,
radiotherapy
infections.
This
report
describes
case
a
55-year-old
man
who
developed
ONHF
after
treatment
with
corticosteroids
for
COVID-19.
can
be
insidious,
manifesting
pain
limited
movement,
magnetic
resonance
imaging
(MRI)
being
most
effective
diagnostic
method.
Treatment
varies
from
conservative
to
surgical,
depending
on
stage
disease.
Early
diagnosis
multidisciplinary
follow-up
are
essential
better
prognosis.
Future
research
should
focus
developing
COVID-19
guidelines
that
reduce
incidence
ONCF,
exploring
safe
therapeutic
alternatives.
Research Square (Research Square),
Год журнала:
2022,
Номер
unknown
Опубликована: Апрель 26, 2022
Abstract
Background:
COVID-19
is
relatively
a
new
condition,
the
long-term
effects
of
which
have
not
been
thoroughly
studied
yet.
Musculoskeletal
complications
following
infection
or
because
its
medications
used
had
reported
in
literature.
Here,
we
report
on
seven
hips
four
patients
who
presented
with
osteonecrosis
femoral
head
(ONFH)
after
having
and
their
treatment
regimen
included
glucocorticoid.
Cases
presentation:
Four
to
us
complaining
hip
pain
(bilateral
three
unilateral
one),
all
being
diagnosed
as
infection,
line
management
corticosteroids
intake
for
various
durations.
The
diagnosis
was
confirmed
by
plain
radiographs
magnetic
resonance
imaging.
disease
early
stages
without
collapse.
Thus,
were
treated
core
decompression.Conclusion:
ONFH
real
concern
especially
when
administered
part
management.
A
follow-up
screening
strategy
should
be
established
detect
development
osteonecrosis.
The Egyptian Orthopaedic Journal,
Год журнала:
2023,
Номер
58(2), С. 67 - 82
Опубликована: Апрель 1, 2023
Abstract
Background
The
pandemic
of
COVID-19
virus
had
led
to
another
avascular
necrosis.
Aim
To
evaluate
the
altered
clinical
and
radiological
presentation
COVID-19-related
AVN
hip.
Methods
This
study
included
42
patients
with
head
femur
who
were
presented
outpatient
clinic
Kafr
El
Sheikh
University
Hospital.
Patients
classified
into
three
main
groups.
first
group
COVID
infection
received
steroid
therapy
for
their
pulmonary
manifestations.
second
without
receiving
therapy.
final
hip
after
vaccination
taking
any
Results
related
infection.
more
susceptible
development
at
(a)
lower
threshold
dose
(900
g)
(b)
earlier
onset
(less
than
a
month).
Conclusions
conclude,
there
is
silent
epidemic
cases
presenting
daily
in
our
clinics
AVN.
